share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thompson Matthew

SEC ·  Jun 29 08:57
Summary by Futu AI
In a recent transaction, Matthew Thompson, associated with Vivos Therapeutics, Inc. [VVOS], executed a stock transaction on June 20, 2024. The specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed. This event may be of interest to investors who follow Vivos Therapeutics, as insider transactions can provide insights into the company's financial health and future prospects.
In a recent transaction, Matthew Thompson, associated with Vivos Therapeutics, Inc. [VVOS], executed a stock transaction on June 20, 2024. The specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed. This event may be of interest to investors who follow Vivos Therapeutics, as insider transactions can provide insights into the company's financial health and future prospects.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.